Clinical Trials in Arizona

Showing 11801-11820 of 14,395 trials

Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors

NCT00413322

This is a study to assess the combination of PXD101 and 5-Fluorouracil (5-FU)in patients with advanced solid tumors. The primary goal of the study is to understand the safety, anti-tumor activity, and how the study drug behaves within the body when given with 5-Fluorouracil (5-FU).

Tumor

Valerio Therapeutics35 participantsStarted Sep 2005

Scottsdale, Arizona, United States • Omaha, Nebraska, United States • Portsmouth, New Hampshire, United States

COMPLETEDPhase 331 miles

Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis

NCT00073021

This study is a prospective clinical study to evaluate the safety and efficacy of two different doses of Asacol for the treatment of moderately active ulcerative colitis. In addition, a new tablet formulation will be evaluated at one of the two doses.

Ulcerative Colitis

Warner Chilcott386 participantsStarted Sep 2000

Scottsdale, Arizona, United States • Anaheim, California, United States • Los Angeles, California, United States +54 more locations

Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors

Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis

Find Trials by Condition in Arizona

Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone

TMC114-C214: Trial of TMC114 Administered With Low Dose Ritonavir (RTV) in HIV-1 Infected Treatment Experienced Patients

A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)

A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma

Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma

MGCD0103 Administered in Combination With Azacitidine (Vidaza®) to Subjects With Relapsed or Refractory Hodgkin or Non-Hodgkin Lymphoma

Safety and Efficacy Study of ADL5859 in Participants With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

Rollover Study of VX-770 in Cystic Fibrosis Subjects

Multicenter, Prospective, Rand, PK Study of LCP-Tacro™ Compared to Prograf® Capsules in De Novo Adult Kidney Transplant

Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia

Tivantinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors

Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery

Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

A Phase 2 Study of the Safety and Efficacy of Thymosin Beta 4 for Treating Corneal Wounds

A Phase 1 Safety Study of LY2127399 in Combination With Bortezomib

A Phase 2/ 3 Trial to Evaluate the Efficacy and Safety of BAY86-6150

Picosecond Laser for Ttreatment of Benign Pigmented Lesions

MANAGE Automated Glucose Monitoring